The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of a common genetic variant of the IGF1 gene with clinical outcome in patients with HER2-positive breast cancer.
A. Lang
No relevant relationships to disclose
A. Muendlein
No relevant relationships to disclose
B. L. Hartmann
No relevant relationships to disclose
H. Drexel
No relevant relationships to disclose
T. Decker
No relevant relationships to disclose
H. Fricke
No relevant relationships to disclose
W. Hofmann
No relevant relationships to disclose
E. Mueller-Holzner
No relevant relationships to disclose
C. Marth
No relevant relationships to disclose
M. Hubalek
No relevant relationships to disclose